Bay Area ge­nomics start­up emerges from stealth with $600M in the bank and promis­ing a '$100 genome' test

When talk­ing about ge­nomics biotechs, fi­nanc­ing rounds tend to be more on the mod­est side — an $18.5 mil­lion Se­ries A round for one, $21 mil­lion ven­ture eq­ui­ty fi­nanc­ing raise for an­oth­er, and $98 mil­lion for Al­ice Zhang’s Verge Ge­nomics Se­ries B from late last year.

But all of those pale in com­par­i­son to a new Cal­i­for­nia ge­nomics out­fit, emerg­ing from stealth Tues­day with an eye-pop­ping $600 mil­lion from a range of blue-chip in­vestors since its found­ing in 2016. The name is Ul­ti­ma Ge­nomics, led by for­mer tech ex­ec­u­tive Gi­lad Al­m­o­gy as both founder and CEO.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER